HEdia eXercise Algorithm - HEXA Study.

NCT ID: NCT05458167

Last Updated: 2024-06-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-03

Study Completion Date

2024-04-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomised controlled crossover pilot study to evaluate safety and efficacy of a digital insulin bolus calculator with a physical activity module

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hedia Diabetes Assistant is a software device intended to monitor blood glucose and to support in the decision making of the optimal bolus insulin dose for management of insulin-dependent diabetes by providing the user with an indicative Bolus insulin dose.

This study has been designed to investigate the safety and efficacy of a digital insulin bolus calculator with a physical activity module that provides guidance on insulin reduction to patients with type 1 diabetes mellitus prior to and after exercise, based on exercise duration and intensity compared with the patients' habitual diabetes management.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Device: Hedia Diabetes Assistant with physical activity module.

The participants will take part in a 45-minute moderate-intensity exercise bout on a stationary ergometer bike. Participants will use the Hedia Diabetes Assistant bolus calculator with the physical activity module (intervention) during a 24-hour period starting one hour before the bout of exercise.

Group Type EXPERIMENTAL

Hedia Diabetes Assistant bolus calculator with a physical activity module

Intervention Type DEVICE

Hedia Diabetes Assistant bolus calculator with a physical activity module is a software device that calculates an insulin bolus based on blood glucose, carbohydrates and physical activity.

Usual treatment

The participants will take part in a 45-minute moderate-intensity exercise bout on a stationary ergometer bike. Participants will use their habitual diabetes management approach during a 24-hour period starting one hour before the bout of exercise (control).

Group Type ACTIVE_COMPARATOR

Hedia Diabetes Assistant bolus calculator with a physical activity module

Intervention Type DEVICE

Hedia Diabetes Assistant bolus calculator with a physical activity module is a software device that calculates an insulin bolus based on blood glucose, carbohydrates and physical activity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hedia Diabetes Assistant bolus calculator with a physical activity module

Hedia Diabetes Assistant bolus calculator with a physical activity module is a software device that calculates an insulin bolus based on blood glucose, carbohydrates and physical activity.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent.
* Ability to understand, speak and read Danish fluently.
* Diagnosis of type 1 diabetes mellitus for ≥12 months.
* Age between ≥18 and \<60 years.
* Minimum one measurement of HbA1c between 6.0 to 8.6 % (42 to 70 mmol/mol) within the last four months. If several measurements, then it is the latest one that counts.
* Body mass index (BMI) between ≥18.5 and \<30 kg/m2.
* Ability to use an Apple® (iOS version 13 and up) or Android® (Android version 8.0 and up) smartphone.
* Treated with the same pen-based insulin regimen with basal insulin (insulin glargine, degludec, or detemir) and meal time insulin (insulin aspart, lispro, glulisine) for at least the three preceding months.
* Patients who can perform 45 min. of exercise at moderate intensity on an ergometer bike (investigator assessment).
* If female participants of childbearing potential; willing to have a pregnancy test performed and to use a highly effective method of contraception.

Exclusion Criteria

* Already using Hedia Diabetes Assistant.
* Use of human insulin or premixed insulin.
* Blood pressure \> 180/105 mmHg.
* Treatment with sodium-glucose transporter 2-inhibitors, glucagon-like peptide 1 receptor agonists, or glucocorticoids.
* Job situation entailing night shifts.
* Fever.
* A mental state impeding compliance with the protocol.
* Expected non-compliance with the protocol at the discretion of the principal investigator.
* Pregnancy.
* Breast-feeding.
* Dialysis therapy or eGFR \< 60 ml/min.
* Patients diagnosed with claudicatio intermittens, heart failure, ischaemic heart disease or stroke.
* Patients prescribed with beta blockers.
* Abuse of alcohol or drugs in the past two years.
* On-going participation, or participation within the last 3 months, in an organised clinical study in which participants received study medication (investigator assessment).
* Surgery scheduled for the study duration period.
* An episode of diabetic ketoacidosis or severe hypoglycaemia requiring third-party assistance within the preceding 6 months.
* Known gastroparesis.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hedia ApS

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Anne Østerskov

Role: STUDY_DIRECTOR

Hedia ApS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

North Zealand Hospital - Hillerød

Hillerød, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HEXA study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study for Patients With Type 1 Diabetes Mellitus
NCT00447213 COMPLETED PHASE2/PHASE3
Starter Kit Study in Insulin naïve Patients
NCT03365180 COMPLETED PHASE2/PHASE3